Work

496 - Conjunctivitis does not increase with longer duration of lebrikizumab exposure in patients with moderate-to-severe atopic dermatitis

Year: 2024

Type: article

Source: British Journal of Dermatology

DOI: 10.1093/bjd/ljad498.007

Authors: April Armstrong, Andreas Wollenberg, Marjolein de Bruin-Weller, Peter Lio, Chitra R Natalie, Fangyi Zhao, Amber Reck Atwater, Gemma Jimenez, Chia-Yu Chu, Christian Vestergaard

Institutions: University of California, Los Angeles, University Hospital Augsburg, Ludwig-Maximilians-Universität München, University Medical Center Utrecht, Northwestern University, Eli Lilly (United States), Almirall (Spain), National Taiwan University, National Taiwan University Hospital, Aarhus University

Language: English

Topic: Dermatology and Skin Diseases

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4391609128

FWCI: 0.342

Cites:

Cited by: 1

Related to: 10